Ternium S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K reports the resolutions adopted at the Annual and Extraordinary General Meetings of Shareholders of Ternium S.A. held on May 6, 2025. The filing covers the approval of consolidated financial statements for the years ended December 31, 2024, 2023, and 2022, and the allocation of results for the fiscal year ended December 31, 2024.
Key Financial Metrics and Dividend Allocation
- Dividend Declaration: The meeting approved a total dividend of USD 0.27 per share (USD 2.70 per ADS) for the year ended December 31, 2024.
- Payment Schedule: An interim dividend of USD 0.09 per share was paid on November 21, 2024. The remaining balance of USD 0.18 per share (USD 1.80 per ADS) is payable on May 14, 2025.
- Total Distribution: The aggregate amount to be distributed on May 14, 2025, is approximately USD 353 million (net of Treasury Shares), funded from retained earnings and the share premium account.
- Net Income/Loss: The filing states that the loss for the year ended December 31, 2024, was absorbed by the Company's retained earnings account. Specific revenue, profit, cash flow, margin, debt, or liquidity figures are not provided in this text.
Material Changes and Governance Resolutions
- Board Composition: The Board of Directors was maintained at eight members. Five directors were reappointed, and Ms. Alicia Lucía Mándolo was appointed as a new member.
- Director Compensation (2025): Standard compensation set at USD 115,000 per director. The Chairman receives an additional USD 295,000. Audit Committee members receive an additional USD 55,000, with the Chairman of the Audit Committee receiving an additional USD 20,000.
- Auditor Appointment: PricewaterhouseCoopers was appointed as the independent auditor for the fiscal year ending December 31, 2025. Fee caps were approved in seven currencies, including a maximum of USD 374,699 for U.S. Dollar-denominated services.
- Share Capital Renewal: The authorized share capital was renewed at USD 3.5 billion (3.5 billion shares with a par value of USD 1). The authorization is valid for five years from the publication of the meeting minutes.
- Pre-emptive Rights: The Board was authorized to waive pre-emptive subscription rights for share issuances, subject to specific exceptions for IPOs, non-cash contributions, and employee incentive plans (up to 1.5% of issued share capital).
Guidance, Outlook, and Risks
The filing text does not provide specific management guidance, financial outlook, or detailed risk factors for future periods. The document focuses strictly on the ratification of past financial results and corporate governance resolutions. The absorption of the 2024 loss by retained earnings indicates a negative net income position for the period, though the magnitude is not specified in this summary.
Investor Verification Checklist
- Verify the exact magnitude of the 2024 net loss and the specific revenue and EBITDA figures in the full 2024 Annual Report referenced in the filing.
- Confirm the total number of outstanding shares to validate the USD 353 million dividend payout calculation.
- Review the full 2024 Annual Report for details on debt levels, liquidity ratios, and segment performance not included in this 6-K summary.
- Monitor the May 14, 2025, dividend payment date and any potential amendments to payment terms by the Board.
- Check for any subsequent filings regarding the utilization of the renewed authorized share capital or waivers of pre-emptive rights.